NCT00763178View on ClinicalTrials.gov

Effects of Duloxetine on Fear Conditioning in Posttraumatic Stress Disorder (PTSD)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

December 31, 2009

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

Duloxetine

"Dosage given according to the following schedule:~Week 1: 30mg QD, Week 2: 60mg QD, Week 3: 60mg QD, Week 4-6: Flexible dosing according to clinical situation, dose range between 60-120mg QD, Weeks 7 + 8: fixed dose"

Trial Locations (1)

06516

VA Connecticut Healthcare System, West Haven

All Listed Sponsors
collaborator

VA Connecticut Healthcare System

FED

lead

Yale University

OTHER

NCT00763178 - Effects of Duloxetine on Fear Conditioning in Posttraumatic Stress Disorder (PTSD) | Biotech Hunter | Biotech Hunter